|Articles|October 9, 2013
Video: The impact of Transparency
George Mina, Pfizer's Director/TL-Data Strategy & Reconciliation-Transparency Medical Division - External Medical Communications, on the challenges of implementing the Physician Payment Sunshine Act for pharmaceutical companies
Advertisement
George Mina, Pfizer's Director/TL-Data Strategy & Reconciliation-Transparency Medical Division - External Medical Communications, on the challenges of implementing the Physician Payment Sunshine Act for pharmaceutical companies.
For more videos tune in to:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
3
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
4
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
5